Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Request for Pharmacist

 
Establishing/Expanding MediTrack system for pharmaceutical products
Terms of Reference: Pharmacist
National E-health Program
 
1- Background

For several years, the Ministry of Public Health (MoPH) has been working on pharmaceutical sector reform, which has positively impacted the quality, safety, and efficacy of pharmaceutical products, as well as Lebanon's overall health status.

In 2018, the MoPH began the process of implementing the National Barcode System in Lebanon by requesting that all registered pharmaceutical importers and local manufacturers who intend to import or produce pharmaceutical products use the 2D Matrix Barcode, as per the standards of the "Global Standards One" GS1, on the outer pack of all registered/under-registration pharmaceutical products. The "MediTrack" pharmaceutical traceability information system was created to connect all stakeholders in the supply chain in a single network and allow them to share information.

Since 2020, the "MediTrack" system has been implemented in all drugstores (around 200) to track imported medications all the way back to the supplier's purchase and distribution.

In 2022, due to the limited budget allocated by the Lebanese central bank for total subsidization of catastrophic illness medications, there is an urgent need to track the dispensing of cancer medications up to the patient level in both the public and private sectors.

In September 2022, a pilot phase was launched to connect hospitals and community pharmacies with WHO support to test the system, evaluate its feasibility, time, and cost, and identify gaps to improve system performance prior to a full-scale project implementation.

The first phase of the project was completed successfully by developing the MediTrack system in accordance with GS1 requirements, testing the software program, and conducting a pilot run with the required stakeholders. MediTrack is now used by 60 hospitals and 180 pharmacies to dispense subsidized catastrophic illness medications to their patients. There are approximately 3800 remaining pharmacies, in addition to the remaining hospitals and PHC centers, that must be linked to MediTrack by 2023.

Following the successful implementation of the NBS at the MOPH with medicine importers and distributors, the MoPH eHealth department launched phase two of the NBS, with WHO support, to achieve the MediTrack goal of tracing all types of medicines all the way up to the patient level.

According to the decision, the inspection department was connected to MediTrack by January 2023, and inspectors began their official role on MediTrack. All imported medications added to MediTrack by importers remain pending until the inspector approves and the products are released to the market.

More than three thousand community pharmacies will be linked to Meditrack, and according to MOPH decree 988, all MOPH registered medications will be distributed to pharmacies through Meditrack beginning in January 2024.

2- Job Description

Under the direct supervision of the Head of the National E-health program (Ms. Lina Abou Mrad), the Pharmacist role is to ensure timely and accurate data related to pharmaceutical products on MoPH data platforms mainly the MediTrack system. The pharmacist will help in establishing rules and procedures for the data validation of pharmaceutical products information systems and will ensure data privacy across MoPH departments and external stakeholders. He/she will also support in the proper implementation at all Meditrack system stakeholders.

3- Job Type

Full Time

4- Work to be Performed.
 
Output 1: Timely and accurately update MediTrack database System through continuous follow-up with pharmacies and health facilities mainly the following tasks:
  • Input non registered medications or donations data into MediTrack.
  • Update the GTIN for the donations and non-registered medications.
  • Update reception data for all donations and non-registered medications on MediTrack (even if products don’t have a 2D barcode).
- Deliverable 1.1: Provide monthly updated number of registered pharmacies through Meditrack on respective database with exchange rates and checking on transactions performed.
- Deliverable 1.2: Provide weekly updated database of from active Meditrack implementers (pharmaceutical companies, manufacturers, importers, wholesalers/distributors)
o Provide monthly status towards reaching the planned targets (ex: number of pharmacies per region connected to the system).
 
Output 2: Conduct visits to Meditrack stakeholders with skills and knowledge to present and respond to inquiries from multiple Meditrack stakeholders.
- Deliverable 2.1: A weekly schedule of visits to community and hospital pharmacies
- Deliverable 2.2: Fill the standard questionnaire , with the ability to respond to inquiries on Meditrack implementation.
- Deliverable 2.3: Report on the status of the Meditrack implementation
 
Output 3: Provide and assist in the training on MediTrack to pharmaceutical companies, hospitals, pharmacies, and all stakeholders.
- Deliverable 3.1: training sessions recording.
- Deliverable 3.2: follow-up with trainees for Meditrack setup and implementation.
 
Output 4: Review pricing and repricing files submitted for local and imported products and calculate the authorized price according to pricing decisions.
- Deliverable 4.1: Review price revisions submitted (for price increase, price decrease, and objections) and provide the accepted authorized price.
- Deliverable 4.2: prepare the drugs pricing Index according to the foreign currency rates provided from BDL.
 
- Perform any other task requested from the Head of the National E-Health Program.
 
5- Specific requirements

Qualifications required: PharmD degree, Master of Science in Pharmacy, or any equivalent degree. Graduates with a bachelor’s degree are eligible if they demonstrate more years of experience.

Experience required:
Essential:Two years’ relevant work experience in pharmaceutical supply chain management. - Proven experience in public related settings. - Lebanese Nationality.
 
Skills / Technical skills and knowledge:
- Strong knowledge of the legal and regulatory frameworks of pharmaceuticals products in Lebanon.
- Proven record of conducting pharmaceutical provision, pharma, and health products management.
- Effective communication, interpersonal and organizational skills.
- General ability to report, draft ideas and concepts, clearly and concisely in written and oral form.
- General ability to research, analyze, evaluate, and synthesize qualitative and quantitative information.
- Computer Skills: Excellent knowledge of Microsoft Office including Word.

Language requirements:
English; Arabic; French (read, write, speak)

6- Place of assignment

Submit your cv to the Ministry of Public Health email address: info@moph.gov.lb 
    3
    ...
ATC Name B/G Ingredients Dosage Form Price
A10BD07 SITAMET G Metformin - 850mg, Sitagliptin - 50mg Tablet, film coated 2,301,079 L.L
R03AK06 SERETIDE DISKUS 100 B Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 100mcg/inhalation Inhalation powder 2,276,469 L.L
N04BA02 SINEMET B Levodopa - 250mg, Carbidopa - 25mg Tablet, scored 1,283,690 L.L
R03AK06 SERETIDE DISKUS 250 B Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation Inhalation powder 2,830,132 L.L
J07AL02 SYNFLORIX B Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg Injectable suspension 4,675,228 L.L
N04BA02 SINEMET B Levodopa - 100mg, Carbidopa - 25mg Tablet 2,742,335 L.L
R03AK06 SERETIDE DISKUS 500 B Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 500mcg/inhalation Inhalation powder 3,723,788 L.L
R03AK06 SEROFLO 500 G Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 500mcg/inhalation Inhalation suspension 2,031,890 L.L
R03AK06 SEROFLO-S 125 G Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 125mcg/inhalation Inhalation suspension 1,212,146 L.L
R03AK06 SEROFLO 250 G Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation Inhalation suspension 1,580,359 L.L
R03AK06 SEROFLO-S 250 G Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 250mcg/inhalation Inhalation suspension 1,725,494 L.L
R03AK07 SYMBICORT B Formoterol fumarate dihydrate - 4.5mcg/Inhalation, Budesonide - 160mcg/Inhalation Inhalation powder 3,378,420 L.L
R03AK07 SYMBICORT TURBUHALER B Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation Inhalation powder 1,689,210 L.L
R03AK07 SYMBICORT B Formoterol fumarate dihydrate - 9mcg/Inhalation, Budesonide - 320mcg/Inhalation Inhalation powder 3,378,420 L.L
R03AL06 SPIOLTO RESPIMAT B Olodaterol HCl - 2.5mcg/puff, Tiotropium bromide monohydrate - 2.5mcg/puff Inhalation solution 5,087,788 L.L
A06AD61 SOFLAX G Lactose - less than 6g/100ml, Galactose - less than 11g/100ml, Lactulose - 67g/100ml Solution 258,018 L.L
A06AX01 SUPPOSITOIRE GLYCERINE ENFANT G Glycerol Stearate USP - Suppository 179,179 L.L
A06AX01 SUPPOSITOIRE GLYCERINE ENFANT G Glycerol Stearate USP - Suppository 179,179 L.L
R01AD09 SINOCORT METERED DOSE G Mometasone furoate - 0.05% 0.05% Spray, suspension 419,279 L.L
B05XA05 SULFATE DE MAGNESIUM PROAMP G Magnesium sulfate - 0.15g/ml 0.15g/ml Injectable solution 1,400,284 L.L
M01AE03 SOLKET INFLAMMATION AND PAIN G Ketoprofen Lysine salt - 0.16% 0.16% Spray 946,065 L.L
N04BC05 SIFROL B Pramipexole (dihydrochloride monohydrate) - 0.18mg 0.18mg Tablet 631,606 L.L
H01CB02 SANDOSTATIN B Octreotide - 0.1mg/ml 0.1mg/ml Injectable solution 1,038,790 L.L
D10AX03 SKINOREN B Azelaic acid - 0.2g/g 0.2g/g Cream 722,987 L.L
N04BC05 SIFROL ER B Pramipexole (dihydrochloride monohydrate) - 0.375mg 0.375mg Tablet, extended release 473,033 L.L
H01CB05 SIGNIFOR B Pasireotide (diaspartate) - 0.3mg/ml 0.3mg/ml Injectable solution 168,719,438 L.L
B05XA03 SODIUM CHLORIDE G Sodium chloride - 0.45% 0.45% Injectable solution 133,856 L.L
B05XA03 SODIUM CHLORIDE G Sodium chloride - 0.45% 0.45% Injectable solution 149,393 L.L
B05XA03 SODIUM CHLORIDE G Sodium chloride - 0.45% 0.45% Injectable solution 163,184 L.L
B05XA03 SODIUM CHLORIDE G Sodium chloride - 0.45% 0.45% Injectable solution 176,974 L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025